arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Hims & Hers Health, Inc.

HIMS Health Care Medical/Nursing Services
$27.71
▼ -5.1% Today
as of Oct 23, 16:34 ET
Last 30 days -3.82% Sep 14 → Oct 23
$27.45 $28.38 $29.31 $30.25 $31.18 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$28.64
High
$29.26
Low
$27.99
Volume
$8M
Avg Vol
$22M
Mkt Cap
$6.9B
P/E (TTM)
—
Beta
—
52w High
$50.99
52w Low
$13.74
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Oct 22 · 21:52 Stocktwits
Telehealth Firm Hims & Hers Seeks Dismissal Of FTC Privacy And Subscription Lawsuit
Oct 21 · 22:04 GuruFocus.com
Hims & Hers Adds Testosterone Injections and an FDA-Approved Pill
Oct 21 · 14:15 MT Newswires
Hims & Hers Launches Injectable, Oral Testosterone Treatments
▸ Show all 25 press releases & news Free account →

HIMS earnings at a glance

Hims & Hers Health, Inc. (HIMS) is scheduled to report earnings on Monday, November 2, 2026 — in 10 days. Analysts expect earnings per share of $0.07, compared with $0.06 in the same quarter last year (+17%). The options market is pricing a move of about ±2.8% after the report, a range of roughly $26.93 to $28.49 from today's $27.71. Over its last 6 reports the stock rose the next day 1 time and fell 5, moving ±8.7% on average; after the most recent report on Aug 10, 2026 it moved -4.0%. That means options currently expect less movement than HIMS has typically delivered. HIMS beat the consensus EPS estimate in 2 of its last 6 reported quarters. Implied volatility is currently 67%. The share price of $27.71 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$14
$51
38% of range
Avg surprise (last 6)
-52.5%
Avg reaction (last 6)
-2.7%
17% positive
Latest IV / EM
67%
EM ±2.8% · $28 · Oct 9

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.18$-0.05$0.07$0.20$0.32 Actual $-0.05Actual $-0.03Actual $-0.04Actual $0.05Actual $0.06Actual $0.32Actual $0.20Est $0.12Actual $0.17Est $0.18Actual $0.06Est $0.09Actual $0.07Est $0.02Actual $-0.18Est $0.04Actual $-0.10Est $-0.07 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-92M$129M$349M$570M$791M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon Aug 10, 2026Jun/2026 $-0.10 $-0.07 -42.9% -141.2% -4.0% earnings
Mon May 11, 2026Mar/2026 $-0.18 $0.04 -550.0% -190.0% -14.1% earnings
Mon Feb 23, 20268K 2026-02-23 $0.07 $0.02 +250.0% — -0.3% earnings
Mon Nov 3, 2025Sep/2025 $0.06 $0.09 -33.3% — -3.6% earnings
Mon Aug 4, 2025Jun/2025 $0.17 $0.18 -5.6% — -12.4% earnings
Mon May 5, 2025Mar/2025 $0.20 $0.12 +66.7% — +18.1% earnings
Mon Sep 30, 2024Sep 2024 $0.32 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.06 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.05 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.04 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.03 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.05 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Nov 2, 2026Sep/2026OTHER $0.07$0.06 +16.7%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$753M$608M—$599M$545M$586M—$402M
Cost of revenue$272M$211M—$157M$129M$155M—$84M
Gross profit$481M$397M—$442M$416M$431M—$318M
Operating income$-97M$-78M—$12M$27M$58M—$22M
Net income$-86M$-92M—$16M$43M$49M—$76M
EPS (diluted)$-0.37$-0.40—$0.06$0.17$0.20—$0.32

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$610M$222M$229M$346M$1.12B$274M$221M$166M
Inventory$88M$79M$80M$106M$142M$76M$64M$49M
Total current assets$1.38B$1.05B$768M$845M$1.36B$447M$396M$326M
Total assets$3.63B$2.27B$2.15B$2.23B$1.88B$892M$708M$602M
Long-term debt————————
Total liabilities$3.30B$1.82B$1.61B$1.65B$1.31B$342M$231M$162M
Total equity$324M$446M$541M$581M$563M$549M$477M$440M

Implied volatility — last 90 days

65%96%126%156%186% Jun 07 — IV 102% · EM ±9.5%Jun 08 — IV 93% · EM ±7.8%Jun 09 — IV 108% · EM ±7.8%Jun 10 — IV 105% · EM ±6.2%Jun 11 — IV 105% · EM ±4.4%Jun 15 — IV 100% · EM ±7.3%Jun 16 — IV 103% · EM ±6.1%Jun 17 — IV 112% · EM ±4.7%Jun 19 — IV 96% · EM ±10.7%Jun 22 — IV 101% · EM ±8.4%Jun 23 — IV 96% · EM ±7.0%Jun 24 — IV 96% · EM ±5.7%Jun 25 — IV 106% · EM ±4.4%Jun 29 — IV 103% · EM ±24.2%Jun 30 — IV 104% · EM ±24.2%Jul 01 — IV 99% · EM ±4.1%Jul 03 — IV 88% · EM ±9.7%Jul 06 — IV 100% · EM ±8.4%Jul 07 — IV 102% · EM ±7.3%Jul 08 — IV 99% · EM ±5.8%Jul 09 — IV 83% · EM ±3.5%Jul 13 — IV 95% · EM ±7.9%Jul 14 — IV 93% · EM ±6.7%Jul 15 — IV 92% · EM ±5.4%Jul 16 — IV 101% · EM ±4.2%Jul 20 — IV 142% · EM ±11.9%Jul 21 — IV 154% · EM ±11.2%Jul 22 — IV 177% · EM ±10.4%Jul 23 — IV 145% · EM ±6.0%Jul 27 — IV 91% · EM ±7.6%Jul 28 — IV 98% · EM ±7.1%Jul 29 — IV 127% · EM ±7.5%Jul 30 — IV 92% · EM ±3.9%Aug 03 — IV 133% · EM ±18.5%Aug 04 — IV 132% · EM ±17.5%Aug 05 — IV 133% · EM ±16.6%Aug 06 — IV 128% · EM ±15.1%Aug 07 — IV 130% · EM ±14.4%Aug 10 — IV 186% · EM ±15.6%Aug 11 — IV 97% · EM ±7.0%Aug 12 — IV 86% · EM ±5.1%Aug 13 — IV 79% · EM ±3.3%Aug 17 — IV 74% · EM ±6.2%Aug 18 — IV 73% · EM ±5.3%Aug 19 — IV 95% · EM ±5.6%Aug 20 — IV 85% · EM ±3.6%Aug 24 — IV 78% · EM ±6.5%Aug 25 — IV 80% · EM ±5.8%Aug 26 — IV 79% · EM ±4.7%Aug 27 — IV 79% · EM ±3.3%Aug 31 — IV 76% · EM ±6.3%Sep 01 — IV 75% · EM ±5.4%Sep 02 — IV 73% · EM ±4.3%Sep 03 — IV 71% · EM ±3.0%Sep 07 — IV 76% · EM ±6.3%Sep 08 — IV 76% · EM ±5.5%Sep 09 — IV 74% · EM ±4.4%Sep 10 — IV 66% · EM ±2.8%Sep 14 — IV 76% · EM ±6.3%Sep 15 — IV 82% · EM ±5.9%Sep 16 — IV 81% · EM ±4.8%Sep 17 — IV 75% · EM ±3.1%Sep 21 — IV 78% · EM ±6.5%Sep 22 — IV 80% · EM ±5.8%Sep 23 — IV 74% · EM ±4.4%Sep 24 — IV 87% · EM ±3.6%Sep 28 — IV 69% · EM ±16.3%Sep 29 — IV 70% · EM ±16.2%Sep 30 — IV 78% · EM ±4.6%Oct 01 — IV 79% · EM ±3.3%Oct 06 — IV 70% · EM ±5.0%Oct 07 — IV 67% · EM ±4.0%Oct 08 — IV 67% · EM ±2.8%

Sector peers

CHE
Chemed Corp.
$6.6B $512.98+0.3%
OPCH
Option Care Health, Inc.
$4.6B $31.22-0.2%
LFST
LifeStance Health Group, Inc.
$4.6B $12.93+4.9%
AVAH
Aveanna Healthcare Holdings Inc.
$2.7B $13.38+3.0%
PRVA
Privia Health Group, Inc.
$2.6B $22.41-0.3%
ADUS
Addus HomeCare Corporation
$2.1B $121.81+3.3%

HIMS earnings FAQ

When is HIMS's next earnings date?

Hims & Hers Health, Inc. is expected to report on November 2, 2026.

What is HIMS's expected move for earnings?

Options currently price a move of about ±2.8%, or $0.78 per share either way from $27.71.

How does HIMS stock usually react to earnings?

Across the last 6 reports the average next-day move was ±8.7%, up 1 times and down 5 times.

What EPS are analysts expecting from Hims & Hers Health, Inc.?

The consensus estimate is $0.07 per share, versus $0.06 a year ago.

What is HIMS's implied volatility?

HIMS's at-the-money implied volatility is about 67% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in